On 27 September, Jo Groves participated in a meeting in Brussels which brought together patient, academic and government representatives with WHO to consider the role of patients and citizens in priority setting for pharmaceuticals innovation and how this might be expanded on in the revised report.
It was identified that it would be worthwhile to develop case studies on patient involvement in priority setting which can exemplify the benefits and good practice models for patient involvement in this area. IAPO members have been sent a survey and we would encourage you to respond if you do have good examples as these will support further patient involvement in this area in the future.
Do you have an example of successful patient involvement in priority setting? Complete the questionnaire on Survey Monkey or contact email@example.com